Literature DB >> 7531173

Variability of hepatitis C virus.

P Simmonds1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7531173      PMCID： PMC7165699     

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  98 in total

1.  HCV genotypes in chronic hepatitis C and response to interferon.

Authors:  K Kanai; M Kako; H Okamoto
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

2.  Hypervariable regions in the putative glycoprotein of hepatitis C virus.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; S Ohkoshi; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

3.  Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism.

Authors:  C Wang; P Sarnow; A Siddiqui
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Imported hepatitis C virus genotypes in Japanese hemophiliacs.

Authors:  T Kinoshita; K Miyake; H Okamoto; S Mishiro
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

5.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.

Authors:  E A Brown; H Zhang; L H Ping; S M Lemon
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

7.  Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

Authors:  K Hino; S Sainokami; K Shimoda; S Iino; Y Wang; H Okamoto; Y Miyakawa; M Mayumi
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

8.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

Authors:  A J Weiner; H M Geysen; C Christopherson; J E Hall; T J Mason; G Saracco; F Bonino; K Crawford; C D Marion; K A Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction.

Authors:  H Miyamoto; H Okamoto; K Sato; T Tanaka; S Mishiro
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

10.  Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo.

Authors:  Y Higashi; S Kakumu; K Yoshioka; T Wakita; M Mizokami; K Ohba; Y Ito; T Ishikawa; M Takayanagi; Y Nagai
Journal:  Virology       Date:  1993-12       Impact factor: 3.616
View more
  103 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy.

Authors:  P Dentico; N Curatolo; R Sacco; M De Luca; A Volpe; C Ranieri; C Genchi; L Petracca; R Buongiorno
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

3.  Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey.

Authors:  Esra Yildiz; Asli Oztan; Funda Sar; Ergun Pinarbasi; Rengul Cetin-Atalay; Hikmet Akkiz; Mehmet Ozturk
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

4.  Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio.

Authors:  S Mihm; H Hartmann; A Fayyazi; G Ramadori
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 5.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

6.  Application of restriction display PCR technique in the preparation of cDNA microarray probes.

Authors:  Zhao-Hui Sun; Wen-Li Ma; Bao Zhang; Yi-Fei Peng; Wen-Ling Zheng
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

7.  Hepatitis C hypervariable region 1: association of reduced selection pressure in african americans with treatment failure.

Authors:  Vicki M Park; Barbara C Mason; Julia Krushkal; Rongling Li; Caroline Riely; Jaquelyn Fleckenstein
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

8.  Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina.

Authors:  Sead Ahmetagic; Nermin N Salkić; Elmir Cickusic; Enver Zerem; Slavica Mott-Divković; Nijaz Tihic; Arnela Smriko-Nuhanovic
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

9.  Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.

Authors:  J T Stapleton; D Klinzman; W N Schmidt; M A Pfaller; P Wu; D R LaBrecque; J q Han; M J Phillips; R Woolson; B Alden
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology.

Authors:  J Detmer; R Lagier; J Flynn; C Zayati; J Kolberg; M Collins; M Urdea; R Sánchez-Pescador
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.